Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award
13 Julho 2023 - 5:01PM
Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company
pioneering a novel technology for bioengineering fully
transplantable organs to help save and improve patients' lives,
announced that its poster entitled Initial Preclinical Evaluation
of a Bioengineered Kidney was selected Best in Congress at the
recent American Transplant Congress (ATC).
"We appreciate the opportunity to present our kidney work at
ATC, and it was an honor to receive the Best in Congress
acknowledgment," said Jeff Ross, Ph.D., Miromatrix CEO.
"Thanks to our talented team of scientists, including David Lo, for
advancing our work to someday provide new options to the thousands
of patients who need a kidney transplant."
Also at ATC, Jack Lake, MD, Miromatrix Medical Director,
received the American Society of Transplantation's (AST) 2023
Lifetime Achievement Award. The award - the Society's highest honor
– recognizes Dr. Lake's outstanding achievements and contributions
to the AST and the field of transplantation.
About MiromatrixMiromatrix Medical Inc. is
a life sciences company pioneering a novel technology for
bioengineering fully transplantable human organs to help save and
improve patients' lives. The Company has developed a proprietary
perfusion technology platform for bioengineering organs that it
believes will efficiently scale to address the shortage of
available human organs. The Company's initial development focus is
on human livers and kidneys. For more information,
visit miromatrix.com.
Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com
Media Contact:
Christina Campbell
612-924-3793
Christina@media-minefield.com
MiroMatrix Medical (NASDAQ:MIRO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
MiroMatrix Medical (NASDAQ:MIRO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024